课题基金 / 基金详情

项目摘要

项目成果

John D Catravas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core B will have three specific aims. Specific Aim 1 is to harvest, characterize and propagate human lung microvascular endothelial cells from subjects undergoing lobectomy or pneumonectomy at MCG Health Inc.; provide said cells to investigators in all four projects for permeability, analytical and other molecular studies. Specific Aim 2 is to create and supply to all four projects mice with ALI induced by intra-tracheal instillation of gram positive or gram negative bacterial products. Specific Aim 3 is to perform in vivo lung capillary permeability (Evan's Blue Dye Method) measurements and lung function (airway mechanics) measurements for studies designed by each of the four projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antidotes against HCI-induced chronic lung injury
  • 批准号:
    10015581
  • 项目类别:
  • 资助金额:
    $45.88万
  • 财政年份:
    2020
  • 负责人:
    John D Catravas
  • 依托单位:
Antidotes against HCI-induced chronic lung injury
  • 批准号:
    10241958
  • 项目类别:
  • 资助金额:
    $45.28万
  • 财政年份:
    2020
  • 负责人:
    John D Catravas
  • 依托单位:
Antidotes against HCI-induced chronic lung injury
  • 批准号:
    10471329
  • 项目类别:
  • 资助金额:
    $44.0万
  • 财政年份:
    2020
  • 负责人:
    John D Catravas
  • 依托单位:
Antidotes against mustard-induced chronic lung injury
  • 批准号:
    9789315
  • 项目类别:
  • 资助金额:
    $19.38万
  • 财政年份:
    2018
  • 负责人:
    John D Catravas
  • 依托单位:
海外基金